METHODS OF TREATING A MULTIPLE SCLEROSIS PATIENT WITH ANTI-VLA-4 THERAPY
www.patentreply.ai/tools/patent-expiration/US12105090Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.
Learn how PTE is calculatedMethods Of Treating A Multiple Sclerosis Patient With Anti-vla-4 Therapy
Application No. 16211154
May 31, 2032
5y 282d remainingEarliest effective filing
May 31, 2012
+ 20 years
May 31, 2032
PTA +751d
Jun 21, 2034
TD cap (US 12066442)
May 31, 2032
Final
May 31, 2032
Filing Date
December 5, 2018
Earliest Effective Filing
May 31, 2012
Issue Date
October 1, 2024
PTA
+751 days
Base Expiry (before PTA)
May 31, 2032
Methods Of Treating A Multiple Sclerosis Patient With Anti-vla-4 Therapy
Filing Date
Dec 5, 2018
Earliest Effective Filing
May 31, 2012
Issue Date
Oct 1, 2024
PTA
+751 days
Calculated Expiration
Jun 21, 2034
Method Of Assessing Risk Of Pml
Filing Date
Aug 3, 2021
Earliest Effective Filing
May 31, 2012
Issue Date
Aug 20, 2024
PTA
0 days
Calculated Expiration
May 31, 2032
Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.